Detalhe da pesquisa
1.
Structure-based classification predicts drug response in EGFR-mutant NSCLC.
Nature
; 597(7878): 732-737, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34526717
2.
Inhibition of nonsense-mediated decay rescues p53ß/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers.
J Biol Chem
; 297(5): 101163, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34481841
3.
Protein arginine methyltransferase 5 is essential for growth of lung cancer cells.
Biochem J
; 446(2): 235-41, 2012 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22708516
4.
IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC.
Clin Cancer Res
; 29(7): 1292-1304, 2023 04 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36595561
5.
MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma.
Cancer Cell
; 41(7): 1363-1380.e7, 2023 07 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37327788
6.
Selection of brain metastasis-initiating breast cancer cells determined by growth on hard agar.
Am J Pathol
; 178(5): 2357-66, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21514446
7.
STK11/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition.
Clin Cancer Res
; 27(6): 1720-1733, 2021 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33323404
8.
Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent Phenotype.
J Thorac Oncol
; 16(3): 439-451, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33309987
9.
Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis.
Am J Pathol
; 174(5): 1972-80, 2009 May.
Artigo
Inglês
| MEDLINE | ID: mdl-19349357
10.
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.
Cancer Cell
; 36(4): 444-457.e7, 2019 10 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31588020
11.
Differential growth of IFN-beta-engineered tumor cells in nude and IFN receptor-null mice.
J Interferon Cytokine Res
; 26(2): 108-18, 2006 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-16487031
12.
Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland.
J Mol Endocrinol
; 36(3): 463-83, 2006 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-16720717
13.
Inhibition of PDGFR phosphorylation and Src and Akt activity by GN963 leads to therapy of human pancreatic cancer growing orthotopically in nude mice.
Int J Oncol
; 29(1): 125-38, 2006 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-16773192
14.
Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Clin Cancer Res
; 11(12): 4512-20, 2005 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-15958637
15.
Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.
Clin Cancer Res
; 8(9): 2942-51, 2002 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-12231540
16.
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.
Cancer Cell
; 37(3): 420, 2020 Mar 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32183953
17.
Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer.
Neoplasia
; 13(2): 167-79, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21403842
18.
[Effects of microbial inoculation on composting in a bioreactor].
Huan Jing Ke Xue
; 30(11): 3409-13, 2009 Nov.
Artigo
Chinês
| MEDLINE | ID: mdl-20063763
19.
Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain.
Cancer Res
; 69(3): 828-35, 2009 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19141644
20.
Selective induction of interleukin-8 expression in metastatic melanoma cells by transforming growth factor-beta 1.
Cytokine
; 31(3): 241-9, 2005 Aug 07.
Artigo
Inglês
| MEDLINE | ID: mdl-15975819